Latest Breaking News On - Davidp southwell - Page 1 : comparemela.com

Needham & Company LLC Reaffirms Buy Rating for Rocket Pharmaceuticals (NASDAQ:RCKT)

Needham & Company LLC Reaffirms Buy Rating for Rocket Pharmaceuticals (NASDAQ:RCKT)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Davidp southwellZurcher kantonalbank zurich cantonalbankHedge funds weigh in on rocket pharmaceuticalsCantor fitzgeraldAllspring global investments holdingsMirae asset global investments coNews ratings for rocket pharmaceuticals dailyAnalyst recommendations for rocket pharmaceuticalsTd asset management incJpmorgan chase coRocket pharmaceuticals trading downInsider transactions at rocket pharmaceuticalsRocket pharmaceuticalsNeedham companyGoldman sachs groupRocket pharmaceuticals inc

Rocket Pharmaceuticals (NASDAQ:RCKT) Issues Quarterly Earnings Results, Beats Estimates By $0 01 EPS

Rocket Pharmaceuticals (NASDAQ:RCKT) Issues Quarterly Earnings Results, Beats Estimates By $0 01 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Kinnari patelDavidp southwellRocket pharmaceuticals incNews ratings for rocket pharmaceuticals dailyJpmorgan chase coGoldman sachs groupSecurities exchange commissionRocket pharmaceuticalsEarnings history for rocket pharmaceuticalsCantor fitzgeraldRocket pharmaceuticals stock performanceRocket pharmaceuticals company profileGet free reportExchange commissionDirector davidRocket pharmaceuticals daily

Rocket Pharmaceuticals, Inc (NASDAQ:RCKT) Given Average Rating of Moderate Buy by Brokerages

Rocket Pharmaceuticals, Inc (NASDAQ:RCKT) Given Average Rating of Moderate Buy by Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandGotham makkerDavidp southwellWellington management groupVanguard group incRocket pharmaceuticals price performanceCantor fitzgeraldInstitutional trading of rocket pharmaceuticalsGoldman sachs groupWestfield capital management coInsider transactions at rocket pharmaceuticalsJpmorgan chase coSecurities exchange commissionNeedham companyRocket pharmaceuticals

PTC Therapeutics (NASDAQ:PTCT) Trading Down 2 9%

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) dropped 2.9% on Tuesday . The company traded as low as $38.61 and last traded at $39.10. Approximately 132,714 shares were traded during trading, a decline of 83% from the average daily volume of 801,563 shares. The stock had previously closed at $40.27. Analyst Ratings […]

United statesHong kongAllan steven jacobsonDavidp southwellSg americas securitiesTherapeutics incChina universal asset management coGoldman sachs groupLazard asset managementHong kong ltdGet free reportTruist financialDirector allan steven jacobsonDirector davidUniversal asset managementAsset management

PTC Therapeutics (NASDAQ:PTCT) PT Raised to $51 00 at Credit Suisse Group

PTC Therapeutics (NASDAQ:PTCT – Get Rating) had its target price increased by Credit Suisse Group from $48.00 to $51.00 in a research report released on Friday morning, The Fly reports. Other research analysts have also recently issued reports about the company. SVB Leerink reissued a market perform rating and issued a $48.00 target price on […]

William blairDavidp southwellAllan steven jacobsonStuart walter peltzLazard asset managementMorgan stanleySecurities exchange commissionAltshuler shaham ltdKinneret advisoryTherapeutics incChina universal asset management coCredit suisse groupRoyal bankGet ratingSuisse groupMarie utter